Business Description
Nanjing Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000KV1
Share Class Description:
SHSE:600713: Class ACompare
Compare
Traded in other countries / regions
600713.China IPO Date
1996-07-01Description
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.21 | |||||
| Debt-to-Equity | 1.5 | |||||
| Debt-to-EBITDA | 7.44 | |||||
| Interest Coverage | 4.54 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.44 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year EBITDA Growth Rate | 14.3 | |||||
| 3-Year EPS without NRI Growth Rate | 15.4 | |||||
| 3-Year Book Growth Rate | 6.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.48 | |||||
| 9-Day RSI | 48.65 | |||||
| 14-Day RSI | 52.79 | |||||
| 6-1 Month Momentum % | 0.42 | |||||
| 12-1 Month Momentum % | -5.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | |||||
| Quick Ratio | 1.2 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 42.28 | |||||
| Days Sales Outstanding | 102.81 | |||||
| Days Payable | 69.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.05 | |||||
| Dividend Payout Ratio | 0.35 | |||||
| 3-Year Dividend Growth Rate | 11.9 | |||||
| Forward Dividend Yield % | 3.05 | |||||
| 5-Year Yield-on-Cost % | 4.59 | |||||
| 3-Year Average Share Buyback Ratio | -7.9 | |||||
| Shareholder Yield % | -20.73 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 6.25 | |||||
| Operating Margin % | 2.93 | |||||
| Net Margin % | 1.07 | |||||
| FCF Margin % | 5.47 | |||||
| ROE % | 8.89 | |||||
| ROA % | 1.83 | |||||
| ROIC % | 6.72 | |||||
| ROC (Joel Greenblatt) % | 15.46 | |||||
| ROCE % | 12.31 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.66 | |||||
| PE Ratio without NRI | 11.26 | |||||
| Shiller PE Ratio | 14.42 | |||||
| Price-to-Owner-Earnings | 21.34 | |||||
| PEG Ratio | 0.71 | |||||
| PS Ratio | 0.12 | |||||
| PB Ratio | 1.01 | |||||
| Price-to-Tangible-Book | 1.06 | |||||
| Price-to-Free-Cash-Flow | 2.25 | |||||
| Price-to-Operating-Cash-Flow | 1.87 | |||||
| EV-to-EBIT | 11.56 | |||||
| EV-to-EBITDA | 11.56 | |||||
| EV-to-Revenue | 0.29 | |||||
| EV-to-FCF | 5.25 | |||||
| Price-to-Projected-FCF | 5.04 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.53 | |||||
| Price-to-Graham-Number | 0.73 | |||||
| Price-to-Net-Current-Asset-Value | 1.75 | |||||
| Earnings Yield (Greenblatt) % | 8.65 | |||||
| FCF Yield % | 43.9 | |||||
| Forward Rate of Return (Yacktman) % | 17.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanjing Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 53,981.062 | ||
| EPS (TTM) (Â¥) | 0.445 | ||
| Beta | 0.82 | ||
| Volatility % | 24.38 | ||
| 14-Day RSI | 52.79 | ||
| 14-Day ATR (Â¥) | 0.189853 | ||
| 20-Day SMA (Â¥) | 5.182 | ||
| 12-1 Month Momentum % | -5.66 | ||
| 52-Week Range (Â¥) | 3.85 - 5.63 | ||
| Shares Outstanding (Mil) | 1,309.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanjing Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanjing Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nanjing Pharmaceutical Co Ltd Frequently Asked Questions
What is Nanjing Pharmaceutical Co Ltd(SHSE:600713)'s stock price today?
The current price of SHSE:600713 is ¥5.19. The 52 week high of SHSE:600713 is ¥5.63 and 52 week low is ¥3.85.
When is next earnings date of Nanjing Pharmaceutical Co Ltd(SHSE:600713)?
The next earnings date of Nanjing Pharmaceutical Co Ltd(SHSE:600713) is .
Does Nanjing Pharmaceutical Co Ltd(SHSE:600713) pay dividends? If so, how much?
The Dividend Yield %  of Nanjing Pharmaceutical Co Ltd(SHSE:600713) is 3.05% (As of Today), Highest Dividend Payout Ratio of Nanjing Pharmaceutical Co Ltd(SHSE:600713) was 0.38. The lowest was 0.1. And the median was 0.29. The  Forward Dividend Yield % of Nanjing Pharmaceutical Co Ltd(SHSE:600713) is 3.05%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers